XTX501, a Tumor-Activated PD1/IL2 Bispecific Molecule, Designed to Stimulate & Expand Antigen-Experienced T cells in the Tumor Microenvironment

Time: 11:40 am
day: Conference Day One


  • Design of XTX501 and key components
  • Rationale for targeting IL-2 to PD1-positive T cells and importance of masking
  • Overview of preclinical data including PK and tolerability in non-human primates